Detalhe da pesquisa
1.
The impact of relapse definition and measures of durability on MS clinical trial outcomes.
Mult Scler;
29(4-5): 568-575, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37119208
2.
Women Connected to at Risk Indian Men Who Have Sex with Men: An Unexplored Network.
AIDS Behav;
19(6): 1031-6, 2015 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25403143
3.
Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis: A Diverse Multicenter Cohort
Neurology;
102(4): e208100, 2024 02 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38261988
4.
Continuous EEG monitoring detects nonconvulsive seizure and Ictal-Interictal Continuum abnormalities in moderate to severe ICANS following systemic CAR-T therapy.
Neurohospitalist;
13(1): 53-60, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36531846
5.
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy.
Mult Scler Relat Disord;
70: 104486, 2023 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36628884
6.
Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis.
Mult Scler Relat Disord;
62: 103737, 2022 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35533419
7.
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy.
medRxiv;
2022 Jun 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35734083
8.
Immunological Aspects of Approved MS Therapeutics.
Front Immunol;
10: 1564, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31354720